Outcomes of Balloon-Expandable TAVR in Younger Patients
Quick Takes
- The current study is a retrospective analysis comparing clinical outcomes among patients younger than 65 years undergoing balloon-expandable TAVR compared to patients older than 65 years.
- Among this cohort, younger patients represented a minority of patients (5.7%), were more likely to have bicuspid anatomy, and more likely to be urgent/emergent cases with high/inoperable risk.
- After adjusting for comorbidities, younger patients had higher readmission rates (28.2% vs. 26.1%; p < 0.001) and similar mortality rates (9.9% vs. 10.1%) at 1 year.
Study Questions:
What are outcomes among patients younger than 65 years who received transcatheter aortic valve replacement (TAVR) using a balloon-expandable valve compared to patients aged 65-80 years?
Methods:
This retrospective registry-based analysis used data on 139,695 patients from the Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry, inclusive of patients 80 years and younger undergoing TAVR from August 2019 to September 2023. Comorbidities (heart failure, coronary artery disease, dialysis, and others) and outcomes (death, stroke, and hospital readmission) of patients younger than 65 years were compared to patients aged 65-80 years.
Results:
In the years surveyed, 13,849 registry patients (5.7%) were younger than 65 years, 125,846 (52.1%) were aged 65-80 years, and 101,725 (42.1%) were 80 years and older. Among those younger than 65 years, the mean (SD) age was 59.7 (4.8) years, and 9,068 of 13,849 patients (65.5%) were male. Among those aged 65-80 years, the mean (SD) age was 74.1 (4.2) years, and 77, 817 of 125,843 patients (61.8%) were male. Those younger than 65 years were more likely to have a bicuspid aortic valve than those aged 65-80 years (3,472/13,755 [25.2%] vs. 9,552/125,001 [7.6%], respectively; p < 0.001). They were more likely to have congestive heart failure, chronic lung disease, diabetes, immunocompromise, and end-stage kidney disease receiving dialysis. Patients younger than 65 years had worse baseline quality of life (mean [SD] Kansas City Cardiomyopathy Questionnaire score, 47.7 [26.3] vs. 52.9 [25.8], respectively; p < 0.001) and mean (SD) gait speed (5-meter walk test, 6.6 [5.8] seconds vs. 7.0 [4.9] seconds, respectively; p < 0.001) than those aged 65-80 years. At 1 year, patients younger than 65 years had significantly higher readmission rates (2,740 [28.2%] vs. 23,178 [26.1%]; p < 0.001) and all-cause mortality (908 [9.9%] vs. 6,877 [8.2%]; p < 0.001) than older patients. When propensity matched, younger patients still had higher 1-year readmission rates (2,732 [28.2%] vs. 2,589 [26.8%]; p < 0.03) with similar mortality to their older counterparts (905 [9.9%] vs. 827 [10.1%]; p = 0.55).
Conclusions:
Among US patients receiving balloon-expandable TAVR for severe aortic stenosis in the low–surgical risk era, those younger than 65 years represent a small subset. Patients younger than 65 years had a high burden of comorbidities and incurred higher rates of death and readmission at 1 year compared to their older counterparts. These observations suggest that heart team decision-making regarding TAVR for most patients in this age group is clinically valid.
Perspective:
The current study is a retrospective analysis comparing clinical outcomes among patients younger than 65 years undergoing balloon-expandable TAVR compared to patients older than 65 years. Among this cohort, younger patients represented a minority of patients (5.7%), were more likely to have bicuspid anatomy, and more likely to be urgent/emergent cases with high/inoperable risk. After adjusting for comorbidities, younger patients had higher readmission rates (28.2% vs. 26.1%; p < 0.001) and similar mortality rates (9.9% vs. 10.1%) at 1 year. Findings from this analysis suggest that risk is determining choice of TAVR in younger patients even in the low-risk TAVR era.
Clinical Topics: Cardiac Surgery, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease, Aortic Surgery, Cardiac Surgery and VHD, Interventions and Structural Heart Disease
Keywords: Age Factors, Aortic Valve Stenosis, STS/ACC TVT Registry, Transcatheter Aortic Valve Replacement
< Back to Listings